Is It Aortic Stenosis or Old Age? Symptoms to Know

Those suffering symptoms of aortic stenosis often write off the warnings as signs of old age. Know how to identify — and address — the real culprit.

7:00 AM

Author | Jane Racey Gleeson

If you or a loved one begins to experience slowdowns or other noticeable health changes such as fatigue, you might think it's simply a normal part of aging.

But it could be something more severe: aortic stenosis.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Aortic stenosis is a condition in which the aortic valve fails to open fully because of a thickening of the valve leaflets. A resulting decrease in blood flow from the heart to the body causes the heart to work harder to pump blood.

Still, "an individual may not recognize the signs of severe aortic disease because they come on so slowly," says P. Michael Grossman, M.D., an interventional cardiologist at the University of Michigan Frankel Cardiovascular Center.

Severe aortic stenosis is often unpreventable and is most commonly attributed to aging (often in patients 70 and older).

Other causes, however, also can be linked.

Among them: "a buildup of calcium deposits that cause narrowing of the valve, radiation therapy, infection or a history of rheumatic fever," says Grossman. "A person born with an abnormal valve may also develop aortic stenosis later in life."

That's why thorough evaluation by a primary care provider or a cardiologist is critical.

Signs and symptoms of aortic stenosis

As many as 300,000 people in the United States have severe aortic stenosis, with symptoms that often progress slowly, says Grossman.

Of concern, he says, are the signs of aortic stenosis that mirror other health issues often attributed to old age.

Those ailments include:

  • Increasing fatigue and low energy level

  • Chest discomfort

  • Heart murmur

  • Shortness of breath

  • Lightheadedness or dizziness

  • Fainting or passing out

Reaching a diagnosis, then, might first require some self-reflection. 

Grossman often asks his patients to consider what they have trouble doing now compared with their abilities six months or one year ago. Do they experience fatigue or shortness of breath while climbing the stairs, for example, or when mowing the lawn?

"My patients often tell me they just can't do the things they used to do," Grossman says.

Aortic stenosis is typically confirmed via an echocardiogram, a test that helps determine the severity of the condition and the most appropriate treatment.

Treatment for aortic stenosis

According to Grossman, surgical aortic valve replacement (SAVR) is the standard treatment for aortic stenosis. It involves opening a patient's chest to replace his or her aortic valve with a man-made mechanical valve or a tissue valve taken from an animal heart.

However, roughly one-third of patients are not candidates for this type of surgery. Many others may also be at increased risk of SAVR-related complications such as bleeding or infection.

A common alternative approach, Grossman says, is a less-invasive valve replacement option known as transcatheter aortic valve replacement (TAVR). The procedure involves a catheter through which a new valve is inserted via a large artery in the groin or chest.

SEE ALSO: 5 Years Later, 'Life is Good' for One of Michigan's First TAVR Patients

And it's a common solution: Frankel CVC doctors have performed more than 900 TAVR procedures.

That option offers several benefits.

"Because TAVR is less invasive than open-heart surgery, patients experience less downtime and a faster recovery, typically within a matter of days or weeks versus up to three months with an open-heart surgical procedure," Grossman says.


More Articles About: Heart Health Aortic Valve Disease Transcatheter Aortic Valve Replacement (TAVR) Frankel Cardiovascular Center Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories pill bottle spilling yellow blue
Health Lab
Nearly 1 in 6 older adults take aspirin despite no history of heart disease
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease, despite stricter guidelines. For some patients, the benefit of aspirin may not outweigh the risk of bleeding.
photo of patient in MRI machine with computers closer up seeing scan
Health Lab
Ischemic stroke: what’s the right treatment?
Most strokes are ischemic, meaning blood flow to part of the brain is blocked by a clot. Here, a neurologist shares treatment options and how providers decide when time is short.
stethoscope blue yellow
Health Lab
Researchers uncover novel mechanism that leads to high blood pressure
Researchers at Michigan Medicine have uncovered a key mechanism that regulates blood pressure and vascular remodeling in people with a genetic variant linked to high blood pressure.
doctors in surgery room over surgery table with cooler open with labels on it
Health Lab
Why donor hearts fail in cold storage — and how to prevent it
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.